Lataa...
Immune checkpoint inhibitors for hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is a leading cause of cancer deaths worldwide, and advanced HCC generally caries a poor prognosis. The treatment of advanced disease is limited to sorafenib, which provides only a limited improvement in survival, and novel therapies are, thus, sorely needed. Among emer...
Tallennettuna:
| Julkaisussa: | Hepat Oncol |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Future Medicine Ltd
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6095178/ https://ncbi.nlm.nih.gov/pubmed/30191042 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/hep-2016-0004 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|